Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

Weight loss drugs like Ozempic and Mounjaro could reshape food delivery habits, as users report eating smaller portions, ...

The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.

The tech-heavy NASDAQ Composite closed 2% on Wall Street on Tuesday, and this selling continued in Asia, with Japan’s Nikkei 225 tumbling over 2% and South Korea’s KOSPI slumping as much as 6% at one ...

The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more heated.

The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) ...

Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues ...

Novo Nordisk once dominated the weight-loss drug market with Wegovy. However, rising competition, particularly from Eli Lilly ...

LONDON () -Wegovy maker Novo Nordisk said on Wednesday that its executive vice president in charge of manufacturing was ...

Novo Nordisk is winding down a range of early-stage programs for liver disease, oncology and stem cells as part of the Danish ...

Novo Nordisk Q3 profit drops on restructuring costs as GLP-1 and obesity drug sales rise; company narrows 2025 growth outlook.

COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year profit and sales forecasts on Wednesday as sales growth ...